The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides
Open accessAbstract
It remains difficult to distinguish tumor recurrence from radiation necrosis after brain tumor therapy. Here we show that these lesions can be distinguished using the amide proton transfer (APT) magnetic resonance imaging (MRI) signals of endogenous cellular proteins and peptides as an imaging biomarker. When comparing two models of orthotopic glioma (SF188/V+ glioma and 9L gliosarcoma) with a model of radiation necrosis in rats, we could clearly differentiate viable glioma (hyperintense) from radiation necrosis (hypointense to isointense) by APT MRI. When we irradiated rats with U87MG gliomas, the APT signals in the irradiated tumors had decreased substantially by 3 d and 6 d after radiation. The amide protons that can be detected by APT provide a unique and noninvasive MRI biomarker for distinguishing viable malignancy from radiation necrosis and predicting tumor response to therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
Padhani, A. R., Liu, G., Mu-Koh, D., Chenevert, T. L., Thoeny, H. C., Takahara, T., Dzik-Jurasz, A., Ross, B. D., Van Cauteren, M., Collins, D., et al. (2009) · Neoplasia · doi:10.1593/neo.81328 · Cited by 1,989
Ward, K. M., Aletras, A. H., & Balaban, R. S. (2000) · Journal of Magnetic Resonance · doi:10.1006/jmre.1999.1956 · Cited by 1,429
Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI
Zhou, J., Payen, J.-F., Wilson, D. A., Traystman, R. J., & van Zijl, P. C. M. (2003) · Nature Medicine · doi:10.1038/nm907 · Cited by 1,198
Self-citationClinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Brandsma, D., Stalpers, L., Taal, W., Sminia, P., & van den Bent, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70125-6 · Cited by 1,121
Chenevert, T. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.24.2029 · Cited by 673
Kumar, A. J., Leeds, N. E., Fuller, G. N., Van Tassel, P., Maor, M. H., Sawaya, R. E., & Levin, V. A. (2000) · Radiology · doi:10.1148/radiology.217.2.r00nv36377 · Cited by 669
Amide proton transfer (APT) contrast for imaging of brain tumors
Zhou, J., Lal, B., Wilson, D. A., Laterra, J., & van Zijl, P. C. M. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10651 · Cited by 660
Self-citationGriffiths, Jr. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.326 · Cited by 594
Howe, F. A., Barton, S. J., Cudlip, S. A., Stubbs, M., Saunders, D. E., Murphy, M., Wilkins, P., Opstad, K. S., Doyle, V. L., McLean, M. A., et al. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10367 · Cited by 539
Chemical exchange saturation transfer imaging and spectroscopy
Zhou, J., & Zijl, P. C. M. V. (2006) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2006.01.001 · Cited by 485
Self-citationClinical Applications of PET in Brain Tumors
Chen, W. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037689 · Cited by 449
Terakawa, Y., Tsuyuguchi, N., Iwai, Y., Yamanaka, K., Higashiyama, S., Takami, T., & Ohata, K. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048082 · Cited by 419
Burger, P. C., Dubois, P. J., Schold, S. C., Smith, K. R., Odom, G. L., Crafts, D. C., & Giangaspero, F. (1983) · Journal of Neurosurgery · doi:10.3171/jns.1983.58.2.0159 · Cited by 397
Wong, J., Armour, E., Kazanzides, P., Iordachita, I., Tryggestad, E., Deng, H., Matinfar, M., Kennedy, C., Liu, Z., Chan, T., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.04.025 · Cited by 364
Self-citationChemical Exchange Saturation Transfer Contrast Agents for Magnetic Resonance Imaging
Sherry, A. D., & Woods, M. (2008) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.151929 · Cited by 356
Gillies, R. J., Raghunand, N., Garcia-Martin, M. L., & Gatenby, R. A. (2004) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2004.1360409 · Cited by 351
Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging
Zhou, J., Blakeley, J. O., Hua, J., Kim, M., Laterra, J., Pomper, M. G., & van Zijl, P. C. M. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21712 · Cited by 338
Self-citationRadiation injury of the brain.
Valk, P. E., & Dillon, W. P. (1991) · PubMed · Cited by 285
Brandes, A. A., Tosoni, A., Spagnolli, F., Frezza, G., Leonardi, M., Calbucci, F., & Franceschi, E. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-008 · Cited by 284
Smith, J. S., Cha, S., Mayo, M. C., McDermott, M. W., Parsa, A. T., Chang, S. M., Dillon, W. P., & Berger, M. S. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.103.3.0428 · Cited by 175
Pseudoprogression and pseudoresponse: Challenges in brain tumor imaging
Clarke, J. L., & Chang, S. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0035-4 · Cited by 170
New advances that enable identification of glioblastoma recurrence
Yang, I., & Aghi, M. K. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.150 · Cited by 153
Magnetic resonance image–guided proteomics of human glioblastoma multiforme
Hobbs, S. K., Shi, G., Homer, R., Harsh, G., Atlas, S. W., & Bednarski, M. D. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10395 · Cited by 139
Quantitative imaging biomarkers in neuro-oncology
Waldman, A. D., Jackson, A., Price, S. J., Clark, C. A., Booth, T. C., Auer, D. P., Tofts, P. S., Collins, D. J., Leach, M. O., & Rees, J. H. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.92 · Cited by 104
Diffusion Imaging for Therapy Response Assessment of Brain Tumor
Chenevert, T. L., & Ross, B. D. (2009) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2009.08.009 · Cited by 50
Ma, J., Zhou-Li, F., Klein–Szanto, A. J., & Gallo, J. M. (1998) · Clinical & Experimental Metastasis · doi:10.1023/a:1006598419541 · Cited by 19
Cited by
Chemical exchange saturation transfer (CEST): what is in a name and what isn't?
van Zijl, P. C. M., & Yadav, N. N. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22761 · Cited by 1,155
Self-citationvan Zijl, P. C. M., Lam, W. W., Xu, J., Knutsson, L., & Stanisz, G. J. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2017.04.045 · Cited by 339
Self-citationZaiss, M., & Bachert, P. (2013) · Physics in Medicine and Biology · doi:10.1088/0031-9155/58/22/r221 · Cited by 323
Pseudoprogression of brain tumors
Thust, S. C., van den Bent, M. J., & Smits, M. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26171 · Cited by 304
Clinical applications of chemical exchange saturation transfer (CEST) MRI
Jones, K. M., Pollard, A. C., & Pagel, M. D. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25838 · Cited by 287
Metadata
- Authors
- Zhou, J., Tryggestad, E., Wen, Z., Lal, B., Zhou, T., Grossman, R., Wang, S., Yan, K., Fu, D.-X., Ford, E., Tyler, B., Blakeley, J., Laterra, J., & van Zijl, P. C. M.
- Venue
- Nature Medicine
- Published
- 2010-12-19
- Volume
- 17
- Issue
- 1
- Pages
- 130-134
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2048919807
- Cited by
- 526
- References
- 27
- FWCI
- 17.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.